Medical Textiles Quality Control Order, 2023

  • 0
  • 3140
Font size:
Print

Medical Textiles Quality Control Order, 2023

Context:

The Ministry of Textiles has officially notified the Medical Textiles (Quality Control) Order, 2023, which is set to come into effect on October 1, 2024.

 

More on News:

  • The Quality Control Order mandates that all products falling under its scope must obtain a Bureau of Indian Standards licence for manufacturing, importing, distributing, selling, hiring, leasing, storing, or displaying products for sale
  • This measure aims to ensure that these widely used products consistently meet essential quality benchmarks, safeguarding both children and adults.

 

Key Highlights of the QCO:

  • Effective Date: October 1, 2024.
  • Products Covered: Sanitary napkins, baby diapers, reusable sanitary pads, and dental bibs.
  • Mandatory BIS Certification: All products must have a BIS licence to be legally manufactured, imported, or sold in India.
  • Exemptions: Small-scale enterprises and Self-Help Groups (SHGs) are exempted from the QCO requirements.

 

Quality Standards:

  • The notified specifications include critical performance criteria such as pH levels, hygiene testing, bacterial and fungal bioburden, biocompatibility evaluations, and biodegradability
  • Notably, there is a strong emphasis on testing for phthalate levels in baby diapers, as these chemicals can pose risks to both users and the environment.

 

Government’s Commitment:

  • This initiative is part of the government’s comprehensive strategy to enhance the quality and safety of essential consumer products. 
  • By enforcing these regulations, the Ministry of Textiles aims to ensure that medical textiles adhere to the highest safety standards, thereby protecting public health and promoting consumer confidence.
Share:
Print
Apply What You've Learned.
Previous Post Integral Humanism
Next Post Biplab Sarma Committee Report
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x